High-dose intravenous glucocorticoid therapy abrogates circulating dendritic cells.
Suda T, Chida K, Matsuda H, Hashizume H, Ide K, Yokomura K, Suzuki K, Kuwata H, Miwa S, Nakano H, Fujisawa T, Enomoto N, Matsushita A, Nakamura H.
Suda T, et al. Among authors: hashizume h.
J Allergy Clin Immunol. 2003 Dec;112(6):1237-9. doi: 10.1016/j.jaci.2003.09.028.
J Allergy Clin Immunol. 2003.
PMID: 14657889
Clinical Trial.
No abstract available.